Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: The impact of COVID-19 on the prognosis of deep vein thrombosis following anticoagulation treatment: a two-year single-center retrospective cohort study

Fig. 5

Cumulative incidence of DVT aggravation or mortality among patients with different diseases in the PSM cohorts. (A) The cumulative incidence of DVT aggravation among patients with advanced lung cancer; (B) The all-cause mortality in patients with advanced lung cancer and DVT; (C) The cumulative incidence of postoperative DVT aggravation; (D) The cumulative incidence of DVT aggravation in patients with benign lung diseases

Back to article page